Tuesday, April 25, 2017

UPDATE 3-Novartis sets sights on return to growth in 2018

* Advances MS drug BAF312 filing date to 2018 from 2019 (Adds $200 mln hit from drug trial failure, closing share price)

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)